Approval for use of the immulite afp on the immulite 1000 automated analyzer.  The device, as modified, will be marketed under the trade name immulite/immulite 1000 afp and is indicated:  for in vitro diagnostic use with the immulite and immulte 1000 analyzers - for the quantitative measurement of alpha-fetoprotein (afp) in either of two contexts: (a) serial measurements in human serum to aid in the management of patients with nonseminomatous testicular cancer; or (b) measurements in maternal serum and amniotic fluid during gestational weeks 15 through 20 - used in conjunction with ultrasonography or amniography - to aid in detection of fetal open neural tube defects.